-
Bovine Insulin as a Metabolic Control Reagent
2026-08-12
Bovine insulin can do more than support cultured-cell growth: it can define the metabolic baseline against which ROS, PDH phosphorylation, and drug response are interpreted. This article connects insulin from bovine pancreas with rigorous assay design informed by melanoma metabolism research.
-
Magnetic Stimulation Targets GABRE in Schizophrenia
2026-08-12
This Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a causal target of selective magnetic stimulation in mice. By combining targeted c-MSST, genetic knockdown, conditional knock-in, behavioral testing, synaptic analysis, and molecular assays, the researchers connect GABRE regulation with the reversal of schizophrenia-like phenotypes.
-
n-Dodecyl-β-D-maltoside in Assay Workflows
2026-08-11
A scenario-driven guide to using n-Dodecyl-β-D-maltoside (SKU C4421) in membrane-protein purification and cell-based assay workflows. It explains how DDM affects solubilization, viability readouts, protocol controls, and vendor selection without assuming that a membrane-protein detergent is biologically inert.
-
From Reporter Signal to Translational mRNA Design
2026-08-11
A thought-leadership guide to using chemically optimized Firefly Luciferase mRNA as a controlled readout for delivery, translation, and carrier biology. The article connects cap and nucleotide engineering with recent rhamnolipid-stabilized nanovaccine research while defining the limits of reporter-based translational inference.
-
Eicosapentaenoic Acid: Applied Lab Workflows
2026-08-10
Build reproducible EPA experiments for membrane remodeling, lipoprotein oxidation, endothelial migration, and cardiovascular disease research. This workflow separates low-micromolar lipid assays from higher-dose cellular studies while translating an emerging arachidonic-acid immunology study into carefully bounded assay ideas.
-
Phosphatase Inhibitor Cocktail 1 in Epigenetic Assays
2026-08-09
Phosphatase Inhibitor Cocktail 1 supports protein phosphorylation preservation during lysis and downstream signaling assays. This guide shows how to integrate it into epigenetic oncology workflows without confusing phosphatase control with evidence of pathway causality.
-
Mycobacterium tuberculosis WecA: Kinetic Study
2026-08-08
This 2026 study establishes a controlled heterologous-expression and purification strategy for Mycobacterium tuberculosis WecA, an 11-transmembrane enzyme involved in mycobacterial cell-wall assembly. By combining affinity purification, mass-spectrometric identification, UMP-based activity detection, and inhibition analysis, the work creates a practical platform for studying WecA catalysis and anti-tuberculosis inhibitor development.
-
Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-08-07
Oligo (dT) 25 Beads provide a magnetic route for isolating polyadenylated eukaryotic mRNA from total RNA or compatible animal and plant samples. They are appropriate for polyA-selected mRNA workflows, but not for unbiased total RNA recovery or transcripts that lack an accessible polyA tail.
-
Caspase-6–Mediated N Protein Cleavage Drives PRRSV Immune Ev
2026-08-07
This study reveals that PRRSV enhances its replication by co-opting host caspase-6 to cleave its nucleocapsid protein at a conserved site, suppressing interferon signaling and facilitating immune evasion. Targeting the caspase-6–N protein interaction emerges as a promising route for antiviral and vaccine development.
-
Calpain Inhibitor I, ALLN: Technical Application Guidance
2026-08-06
Calpain Inhibitor I, ALLN provides selective, potent inhibition of calpain and cathepsin proteases, supporting apoptosis assays and ischemia-reperfusion injury models. It is not suitable for diagnostic or therapeutic use and requires strict adherence to solubility and storage protocols for reliable results.
-
Diethylmaleate: Optimizing Redox and Toxicology Workflows in
2026-08-06
Diethylmaleate unlocks precise control of intracellular glutathione, empowering advanced oxidative stress and pesticide resistance studies. Its validated use as a GST inhibitor enables breakthroughs in redox modulation and toxicology research, as demonstrated in cutting-edge insecticide resistance models.
-
Improving In Vitro Drug Response Evaluation in Cancer Resear
2026-08-05
Schwartz's dissertation advances in vitro drug response evaluation by distinguishing the unique contributions of proliferation arrest and cell death in anti-cancer drug assays. This work provides a more nuanced framework for interpreting viability measurements, with practical implications for optimizing the use of HDAC inhibitors like Vorinostat in cancer biology research.
-
SB743921: Protocols and Troubleshooting for KSP Inhibitor As
2026-08-05
SB743921 is a cutting-edge kinesin spindle protein inhibitor, delivering nanomolar precision for mitotic arrest in diverse cancer research applications. This guide covers workflow setup, protocol enhancements, and expert troubleshooting to help researchers maximize reproducibility and interpretative power in both in vitro and xenograft models.
-
AZD6482: Selective PI3Kβ Inhibition and Translational Impact
2026-08-04
Explore how AZD6482, a potent PI3Kβ inhibitor, is reshaping translational research in thrombosis and metabolic signaling. This in-depth analysis uncovers new assay decisions and mechanistic insights beyond standard protocols.
-
TP53-Dependent Antitumor Effects of DHODH Inhibition in NPC
2026-08-04
Dong et al. provide compelling evidence that targeting dihydroorotate dehydrogenase (DHODH) with BAY2402234 in nasopharyngeal carcinoma (NPC) yields pronounced antitumor effects via TP53 activation. Their integrated transcriptomic and functional studies clarify the centrality of nucleic acid metabolism in NPC progression, positioning DHODH inhibition as a promising therapeutic strategy for TP53-intact tumors.